SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-030527
Filing Date
2023-06-29
Accepted
2023-06-29 06:01:18
Documents
12
Period of Report
2023-06-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K onct-20230628.htm   iXBRL 8-K 118500
  Complete submission text file 0000950170-23-030527.txt   239043

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20230628_lab.xml EX-101.LAB 13760
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20230628.xsd EX-101.SCH 2467
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20230628_pre.xml EX-101.PRE 11000
6 EXTRACTED XBRL INSTANCE DOCUMENT onct-20230628_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 231054125
SIC: 2834 Pharmaceutical Preparations